A New Hope to Cure Type 2 Diabetes Definitely

- in Healthy
180
0

Type 2 diabetes is a lifelong (chronic) illness in which there is a high level of sugar (glucose) in the blood. Type 2 diabetes is the most common form of this disease.

Insulin is a hormone produced in the pancreas by special cells called beta. The pancreas is below and behind the stomach. Insulin is needed to move the sugar in the blood (glucose) to the cells. Within cells, it is stored and subsequently used as an energy source.

A Valencian clinic confirms that it has achieved a 95% success in the cure of type 2 diabetes with a gastric bypass. Confirmed the team of bariatric and metabolic surgeon and responsible for Obesitas clinic, José Vicente Ferrer, Which has consolidated a success rate of between 80 and 85 percent in the treatment of type 2 diabetes, allowing even avoid the use of insulin, thanks to a gastric bypass.

The Valencian clinic has explained in a statement that, in this way, “improves the quality of life of the patient, providing a greater sense of health and limiting the use of insulin.” It is an intervention especially indicated for patients with type 2 diabetes, which allows the patient to suppress the use of insulin, provided that the diabetes is not more than ten years and the pancreatic reserve is sufficient.

For this last aspect, it is necessary to carry out a detailed study, And even a “real test” to know approximately what the pancreatic reserve is and how the pancreas will respond to the operation. In this context, the possibility of being able to leave the insulin is of the 80 percent of the cases, whereas the possibility of reducing notably the units to be administered is of the 95 percent. Obesitas has highlighted, among the main advantages of metabolic surgery, “the halting of the accelerated aging process at micro and macrovascular level that causes diabetes” and, therefore, “all possible future complications.”

What does it consist of?

The sadis bypass consists basically of performing a small stomach and a bypass or bypass of the duodenum and ileum. This technique pursues that the food does not pass through the duodenum and the first part of the small intestine, allowing the patient to lose the excess weight.

The majority of patients undergoing surgery have been able to leave the clinic within 48 hours of the operation, they do not need to inject insulin after the operation, and still have not lost weight in a relevant way, which guarantees their success as an intervention against diabetes . This metabolic surgery operation is indicated for patients with diabetes who appear in adulthood and are associated with an overweight of over 20 kilos, commonly known as diabesity.

The Surgery Service explained that the surgical intervention is similar to that of obesity surgery in which a gastric baipas is performed. EFE The Hospital Clínico de Valencia has pioneered a metabolic or diabetes surgery program that aims to correct type 2 diabetes resistant to treatments with a laparoscopic surgery, similar to the one done To combat obesity.

The head of the Surgery Service of the Hospital Clínico, Joaquín Ortega, explained that the surgical procedure is similar to that of obesity surgery in which a gastric baipas is performed, although in this case the patients are not morbidly obese, but With obesity grade 1. Although the main objective is to correct diabetes, at the same time it is possible to reduce weight, treat cholesterol, hypertension and even obstructive sleep apnea.

Patients undergoing this intervention are patients with refractory type 2 diabetes, who have grade 1 obesity, are aged between 18 and 50 years, diabetes of less than five years of evolution, poor medical control of diabetes and absence of diabetes. Complications of diabetes.

So far interventions have been made in patients with obesity grades 2 and 3 and the results “have shown a striking figure in the reduction of diabetes, which has been completely resolved in more than 80 percent of the cases.” Ortega stressed that good results are expected in the short term with this program, implanted in the Surgery Service in collaboration with Endocrinology.

The intervention consists of making a gastric baipas in the intestine so that the food does not pass through the stomach and duodenum, and arrives, before being completely digested, to the ileum. “This sets in motion a series of hormonal mechanisms, some of which are still partially unknown, which decrease peripheral resistance to insulin, and lower blood sugar to almost normal values,” Ortega explained.

The procedure, which is performed by laparoscopy, lasts approximately 100 minutes, the time of admission is usually three days and the postoperative period requires a convalescence of less than one month. “The results are beginning to be observed the day after the intervention,” according to Ortega.

Facebook Comments

You may also like

50% of All Colon Cancer Cases Can Be Avoided If We Stay Away from These 9 Things

Colon cancer affects around millions of people in